| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 159 | 3,154,376 | ARES, ESGU, CME, SOXX | 13F-HR | 2/8/2024 | 000095012324001063 |
| Q3 2023 | 172 | 3,105,436 | ARES, AGG, LQD, ESGU | 13F-HR | 11/8/2023 | 000095012323009565 |
| Q2 2023 | 174 | 3,144,243 | ARES, AGG, LQD, IGV | 13F-HR | 8/9/2023 | 000095012323006963 |
| Q1 2023 | 165 | 3,191,894 | ARES, LQD, JEF, CME | 13F-HR | 5/11/2023 | 000095012323004382 |
| Q4 2022 | 170 | 2,643,829 | ARES, JEF, CME, LQD | 13F-HR | 2/10/2023 | 000095012323001349 |
| Q3 2022 | 189 | 2,377,183 | ARES, JEF, CME, LQD | 13F-HR | 11/8/2022 | 000095012322011042 |
| Q2 2022 | 198 | 3,562,949 | ARES, SPY, JEF, QQQ | 13F-HR | 8/9/2022 | 000095012322008029 |
| Q1 2022 | 193 | 3,409,443 | ARES, JEF, SQ, CME | 13F-HR | 5/12/2022 | 000095012322005266 |
| Q4 2021 | 186 | 3,480,558 | ARES, JEF, SQ, EMB | 13F-HR | 2/10/2022 | 000095012322001544 |
| Q3 2021 | 181 | 4,380,285 | ARES, JEF, IVV, VOO | 13F-HR | 11/10/2021 | 000095012321014448 |
| Q2 2021 | 162 | 4,543,327 | ARES, QQQ, IVV, SQ | 13F-HR | 8/11/2021 | 000095012321010191 |
| Q1 2021 | 178 | 4,239,642 | ARES, DIA, IVV, LQD | 13F-HR | 5/13/2021 | 000095012321006163 |
| Q4 2020 | 153 | 4,062,977 | ARES, LQD, IVV, AGG | 13F-HR | 2/12/2021 | 000095012321001775 |
| Q3 2020 | 153 | 2,927,283 | LQD, ARES, IVV, VOO | 13F-HR | 11/12/2020 | 000095012320011304 |
| Q2 2020 | 143 | 2,914,706 | SPY, ARES, VOO, QQQ | 13F-HR | 8/14/2020 | 000095012320008731 |
| Q1 2020 | 140 | 2,033,313 | VOO, ARES, QQQ, SPY | 13F-HR | 5/14/2020 | 000095012320004730 |
| Q4 2019 | 126 | 1,271,815 | LQD, IVV, SPY, CME | 13F-HR | 2/14/2020 | 000095012320002033 |
| Q3 2019 | 128 | 1,207,265 | VOO, QQQ, SPY, CME | 13F-HR | 11/8/2019 | 000095012319010320 |
| Q2 2019 | 117 | 1,265,340 | IVV, QQQ, CME, DIA | 13F-HR | 8/9/2019 | 000095012319007373 |
| Q1 2019 | 116 | 1,119,092 | LQD, VOO, SPY, MCHI | 13F-HR | 5/14/2019 | 000095012319004695 |
| Q4 2018 | 106 | 1,581,281 | IVV, LQD, SPY, GLD | 13F-HR | 2/8/2019 | 000095012319000869 |
| Q3 2018 | 113 | 1,229,705 | CME, DIA, LQDH, IVV | 13F-HR | 11/9/2018 | 000095012318010820 |
| Q2 2018 | 102 | 976,117 | LQD, DIA, LQDH, CME | 13F-HR | 8/14/2018 | 000095012318008447 |
| Q1 2018 | 121 | 1,085,986 | LQD, MDY, DIA, CME | 13F-HR | 5/14/2018 | 000095012318005098 |
| Q4 2017 | 103 | 764,367 | LQD, IVV, CME, HYG | 13F-HR | 2/13/2018 | 000095012318001521 |
| Q3 2017 | 101 | 843,790 | IWM, IVV, LQD, CME | 13F-HR | 11/13/2017 | 000095012317010064 |
| Q2 2017 | 114 | 490,188 | LQD, CME, AGG, HYG | 13F-HR | 8/10/2017 | 000095012317006986 |
| Q1 2017 | 80 | 530,209 | SPY, IVV, CME, FXI | 13F-HR | 5/12/2017 | 000095012317004561 |
| Q4 2016 | 35 | 430,905 | SPY, IVV, FXI, EEM | 13F-HR | 2/14/2017 | 000095012317001950 |